NCT02507791

Brief Summary

This study is evaluating the feasibility and efficacy of using Fitbit Charge HR devices to remotely track the physical activity of obese pediatric patients who are concurrently enrolled in a comprehensive weight loss intervention program. Patients will receive Fitbit devices and will be called weekly to review their average daily steps and heart rates. Patients will receive the Fitbit either at the beginning of classes or upon completion of classes. Patients will then be followed remotely and called weekly for 12 additional weeks after completing classes. The two groups will be compared to examine for differences.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started May 2015

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 24, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

February 15, 2022

Status Verified

January 1, 2022

Enrollment Period

11 months

First QC Date

July 21, 2015

Last Update Submit

January 31, 2022

Conditions

Keywords

FitbitObesityPediatrics

Outcome Measures

Primary Outcomes (2)

  • BMI z-score

    12 weeks

  • physical activity as measured by Actigraph

    12 weeks

Secondary Outcomes (15)

  • fasting lipid panel

    12 weeks

  • fasting glucose

    12 weeks

  • fasting insulin

    12 weeks

  • Hemoglobin A1c

    12 weeks

  • Resting energy expenditure

    12 weeks

  • +10 more secondary outcomes

Study Arms (2)

Early Fitbit

EXPERIMENTAL

Patients will receive Fitbit in the first phase of the study. In addition to attending weekly weight management classes, patients will wear Fitbit Charge HR devices to track heart rate, "active minutes," steps taken, calories burned, and sleep patterns. Patients will receive weekly phone calls to review this data, and further recommendations will be given to encourage additional physical activity as clinically indicated based on time spent being physically active. The goal will be for individuals to reach 10,000 steps per day, though if subjects are significantly under that goal, realistic goal-setting (recommended increases of physical activity of 10% at a time). Patients will continue this intervention for 12 weeks. After 12 weeks, they will return for reassessment. This coincides with the completion of the weight loss program. Subjects will then be followed remotely for another 12 weeks and phone call interventions will continue before returning for a final study visit.

Other: Fitbit Charge HR plus weekly phone calls to review physical activity data

Late/Delayed Fitbit

ACTIVE COMPARATOR

These subjects will follow a similar pattern except they will not receive Fitbit Charge HR devices until the second phase of the study (specifically after completion of the 12 week weight loss program). In the first phase, these subjects will receive weekly phone calls to offer them the same attention as the experimental group, but instead of reviewing Fitbit data, these subjects will subjectively report their physical activity in minutes and by qualifying their physical activity as light, moderate, or vigorous. These individuals, after 12 weeks, will return for reassessment. At that time, these individuals will receive Fitbits and receive weekly telephone calls for an additional 12 weeks before returning for a final study visit.

Other: Fitbit Charge HR plus weekly phone calls to review physical activity data

Interventions

Patients during weekly Healthy Kids, Healthy Weight classes will also upload their Fitbit data, which will be remotely accessed by the study team and weekly phone calls will be implemented to discuss activity

Early FitbitLate/Delayed Fitbit

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Enrollment in the Healthy Kids, Healthy Weight assessment and intervention program
  • BMI greater than or equal to the 95th percentile

You may not qualify if:

  • Compromising medical condition that prevents physical activity (sickle cell disease, severe asthma, fractures, etc)
  • Severe intellectual disability
  • History of smoking
  • Current use of atypical antipsychotics, stimulants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UH Rainbow Babies and Children's Hospital

Cleveland, Ohio, 44106, United States

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Fellow

Study Record Dates

First Submitted

July 21, 2015

First Posted

July 24, 2015

Study Start

May 1, 2015

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

February 15, 2022

Record last verified: 2022-01

Locations